Wells Fargo’s BIND THERAPEUTICS INC BIND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,555
Closed -$1K 6622
2016
Q2
$1K Hold
1,555
﹤0.01% 6059
2016
Q1
$3K Sell
1,555
-165
-10% -$299 ﹤0.01% 6005
2015
Q4
$4K Hold
1,720
﹤0.01% 5947
2015
Q3
$8K Hold
1,720
﹤0.01% 5771
2015
Q2
$10K Sell
1,720
-2,270
-57% -$14.1K ﹤0.01% 5832
2015
Q1
$22K Buy
3,990
+655
+20% +$4.03K ﹤0.01% 5355
2014
Q4
$18K Sell
3,335
-2,141
-39% -$16.1K ﹤0.01% 5428
2014
Q3
$47K Buy
5,476
+94
+2% +$927 ﹤0.01% 4964
2014
Q2
$71K Buy
5,382
+418
+8% +$4.09K ﹤0.01% 4837
2014
Q1
$60K Buy
4,964
+2,193
+79% +$28.6K ﹤0.01% 4870
2013
Q4
$41K Buy
+2,771
New +$35.3K ﹤0.01% 4814

Wells Fargo's BIND Position: Q3 2016 in Review

Wells Fargo sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 1,555 shares — an estimated $1K sold.

Wells Fargo first reported a position in BIND in Q4 2013 and held it in 11 quarters. The position peaked at $71K in Q2 2014. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.

  • Wells Fargo reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Wells Fargo sold 1,555 BIND THERAPEUTICS INC shares in Q3 2016, an estimated $1K.
  • Wells Fargo first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 11 quarters.
  • Wells Fargo's BIND THERAPEUTICS INC position peaked at $71K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.

Based on Wells Fargo's 13F filing for Q3 2016, filed 31 Oct 2016.